Article ID Journal Published Year Pages File Type
2082372 Drug Discovery Today: Disease Models 2011 8 Pages PDF
Abstract
Patients with obstructive sleep apnea (OSA) commonly have cognitive complaints. There are few randomized studies that have examined neuropsychological effects of continuous positive airway pressure (CPAP) treatment in patients with OSA. In this double-blind trial, we examined if a three-week CPAP treatment compared with placebo CPAP treatment has specific therapeutic effects on cognitive impairments in patients with OSA and if there are specific domains of cognitive impairments sensitive to three-week CPAP treatment. Thirty-eight newly diagnosed patients with untreated OSA underwent neuropsychological testing before and after three-week CPAP or placebo-CPAP treatment. The two treatment groups (therapeutic CPAP and placebo-CPAP) were compared using repeated measures analysis of variance (ANOVA). Impairments in neuropsychological functioning ranged from 2.6% to 47.1% before treatment. In response to three weeks of treatment, there was no significant time by treatment interaction for a global deficit score of neuropsychological functioning. Only the Stroop Color (number correct) test showed significant improvement specific to CPAP treatment. The study demonstrates the importance of further randomized placebo-controlled studies in this area.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology
Authors
, , , , , , , ,